These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 19145114)

  • 21. Patent foramen ovale presenting as refractory hypoxemia after heart transplantation.
    Ouseph R; Stoddard MF; Lederer ED
    J Am Soc Echocardiogr; 1997; 10(9):973-6. PubMed ID: 9440075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implantation of a second Amplatzer device to eliminate residual shunt after transcatheter patent foramen ovale closure.
    Chessa M; Citro R; Butera G; Provenza G; Bossone E; Carminati M
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):736-7. PubMed ID: 19483639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Percutaneous closure of a patent foramen ovale to prevent paradoxical thromboembolism in a patient with a continuous-flow LVAD.
    Bartoli CR; McCants KC; Birks EJ; Flaherty MP; Slaughter MS
    J Invasive Cardiol; 2013 Mar; 25(3):154-6. PubMed ID: 23468448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of severe and persistent hypoxemia seven months after orthotopic heart transplantation.
    Martín M; Molina BD; de la Hera JM; Bernardo MJ; Hevia S; Barriales R; de la Tassa CM
    Int J Cardiol; 2009 Mar; 133(1):e6-8. PubMed ID: 18068837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Patent Foramen Ovale-Related Hypoxemia After Bilateral Lung Transplant.
    Raavi L; Garg P; Alomari M; Ali M; Wadiwala I; El-Sayed Ahmed MM
    Tex Heart Inst J; 2023 Oct; 50(5):. PubMed ID: 37872694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxemia secondary to right-to-left interatrial shunt through a patent foramen ovale in a patient with an elevated right hemidiaphragm.
    Perkins LA; Costa SM; Boethel CD; Lawrence ME
    Respir Care; 2008 Apr; 53(4):462-5. PubMed ID: 18364058
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials. A science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    J Am Coll Cardiol; 2009 May; 53(21):2014-8. PubMed ID: 19460622
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Percutaneous device closure of patent foramen ovale for secondary stroke prevention: a call for completion of randomized clinical trials: a science advisory from the American Heart Association/American Stroke Association and the American College of Cardiology Foundation.
    O'Gara PT; Messe SR; Tuzcu EM; Catha G; Ring JC; ; ;
    Circulation; 2009 May; 119(20):2743-7. PubMed ID: 19433754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patent foramen ovale appearance with association of left ventricular assist device and mechanical ventilation.
    Marty P; Méjean S; Boudou N; Mayeur N; Minville V; Galinier M
    Am J Emerg Med; 2012 Jan; 30(1):259.e1-3. PubMed ID: 21159467
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of concomitant cardiac procedures performed during implantation of long-term left ventricular assist devices.
    Morgan JA; Tsiouris A; Nemeh HW; Hodari A; Karam J; Brewer RJ; Paone G
    J Heart Lung Transplant; 2013 Dec; 32(12):1255-61. PubMed ID: 24135274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Late complications of transcatheter closure of patent foramen ovale: new technology and new outcomes.
    Staubach S; Bertog S; Wunderlich N; Sievert H
    Future Cardiol; 2009 Sep; 5(5):503-10. PubMed ID: 19715414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictors of recurrent events in patients with cryptogenic stroke and patent foramen ovale within the CLOSURE I (Evaluation of the STARFlex Septal Closure System in Patients With a Stroke and/or Transient Ischemic Attack Due to Presumed Paradoxical Embolism Through a Patent Foramen Ovale) trial.
    Elmariah S; Furlan AJ; Reisman M; Burke D; Vardi M; Wimmer NJ; Ling S; Chen X; Kent DM; Massaro J; Mauri L;
    JACC Cardiovasc Interv; 2014 Aug; 7(8):913-20. PubMed ID: 25147037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombogenicity and Antithrombotic Strategies in Structural Heart Interventions and Nonaortic Cardiac Device Therapy-Current Evidence and Practice.
    Geisler T; Jorbenadze R; Popov AF; Mueller KL; Rath D; Droppa M; Schreieck J; Seizer P; Storey RF; Kristensen SD; Rubboli A; Gorog D; Aradi D; Sibbing D; Huber K; Gawaz M; Ten Berg J
    Thromb Haemost; 2019 Oct; 119(10):1590-1605. PubMed ID: 31421642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Patent foramen ovale and decompression illness in divers].
    Sivertsen W; Risberg J; Norgård G
    Tidsskr Nor Laegeforen; 2010 Apr; 130(8):834-8. PubMed ID: 20418929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Asymptomatic significant patent foramen ovale: giving patent foramen ovale management back to the cardiologist.
    Rigatelli G; Cardaioli P; Chinaglia M
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):573-7. PubMed ID: 18307240
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patent foramen ovale and cryptogenic stroke: the hole story.
    Furlan AJ; Jauss M
    Stroke; 2013 Sep; 44(9):2676-8. PubMed ID: 23908069
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intractable intraoperative hypoxemia secondary to pulmonary embolism in the presence of undiagnosed patent foramen ovale.
    Rajan GR
    J Clin Anesth; 2007 Aug; 19(5):374-7. PubMed ID: 17869991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Closure of a coexisting ostium secundum atrial septal defect and patent foramen ovale using a single Amplatzer patent foramen ovale occluder device.
    Luna M; Banerjee S; Brilakis ES
    Cardiovasc Revasc Med; 2010; 11(1):63-6. PubMed ID: 20129363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biventricular decompression by trans-septal positioning of venous ECMO cannula through patent foramen ovale.
    Madershahian N; Salehi-Gilani S; Naraghi H; Stoeger E; Wahlers T
    J Cardiovasc Surg (Torino); 2011 Dec; 52(6):900. PubMed ID: 21712763
    [No Abstract]   [Full Text] [Related]  

  • 40. Percutaneous closure of patent foramen ovale in cryptogenic embolism.
    Meier B; Kalesan B; Mattle HP; Khattab AA; Hildick-Smith D; Dudek D; Andersen G; Ibrahim R; Schuler G; Walton AS; Wahl A; Windecker S; Jüni P;
    N Engl J Med; 2013 Mar; 368(12):1083-91. PubMed ID: 23514285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.